recall
saveSamsung Bioepis Co., Ltd. recall (Cls II)
November 5, 2025updated 2mo ago
community read0 votes
HADLIMA (adalimumab-bwwd) injection, 40mg/0.8 mL, 2 Single-dose Prefilled Syringes per carton, Rx only, Manufactured for: Organon LLC, a subsidiary of ORGANON & Co, Jersey City, NJ 07302, Manufactured by: SAMSUN BIOEPIS Co., Ltd, Incheon, Republic of Korea, NDC 78206-183-01. — Reason: Lack of Assurance of Sterility. — Status: Ongoing
view source ↗